Where
-Infinity
0
Severity
6.5
Command Injection
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and execute arbitrary code via the usertoken function of default.aspx.

First published (updated )
Severity
6.5
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Clinical Collaboration Platform 12.2.1.5 has a weak logout system where the session token remains valid after logout and allows a remote attacker to obtain sensitive information and execute arbitrary code.

First published (updated )
Severity
6.5
Command Injection
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and execute arbitrary code via the session management component.

First published (updated )
Severity
7.1
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior,

exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.

1 / 2
Source: MITRE

Remedy

Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CVE-2020-16247. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .
First published (updated )
Severity
6.5
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior,

does not properly control the allocation and maintenance of a limited resource, thereby enabling an attacker to influence the amount of resources consumed, eventually leading to the exhaustion of available resources.

1 / 2
Source: MITRE

Remedy

Philips requires manual intervention to remediate CVE-2020-16200. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .
First published (updated )
Severity
6.3
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior. When an attacker claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.

1 / 2

Remedy

Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CVE-2020-16198. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .
First published (updated )
Severity
3.5
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.

1 / 2
Source: MITRE

Remedy

Philips released the Clinical Collaboration Platform patch 12.2.1.5 in June 2020 for web portals to remediate CVE-2020-14525. Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CVE-2020-14525. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .
First published (updated )
Severity
4.3
CSRF
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior. The product receives input or data, but it does not validate or incorrectly validates that the input has the properties required to process the data safely and correctly.

Remedy

Philips released the Clinical Collaboration Platform patch 12.2.1.5 in June 2020 for web portals to remediate CVE-2020-14506. Philips Clinical Collaboration Platform Version 12.2.5 was released in May 2020 to remediate CVE-2020-14506. Users with questions regarding their specific Philips Clinical Collaboration Platform installations and new release eligibility should contact Philips service support, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-877-328-2808, option 4. The Philips advisory and the latest security information for Philips products are available at the Philips product security website https://www.philips.com/productsecurity .
First published (updated )

Contact

SecAlerts Pty Ltd.
132 Wickham Terrace
Fortitude Valley,
QLD 4006, Australia
info@secalerts.co
By using SecAlerts services, you agree to our services end-user license agreement. This website is safeguarded by reCAPTCHA and governed by the Google Privacy Policy and Terms of Service. All names, logos, and brands of products are owned by their respective owners, and any usage of these names, logos, and brands for identification purposes only does not imply endorsement. If you possess any content that requires removal, please get in touch with us.
© 2026 SecAlerts Pty Ltd.
ABN: 70 645 966 203, ACN: 645 966 203